Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENT-MINS
2024-515226-81-00Phase 3Completed
- Sponsor
- Jagiellonian University Medical College
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ivabradine and Placebo-COD Research Private Ltd in Myocardial injury (2 arms), sponsored by Jagiellonian University Medical College. Primary endpoint: Myocardial injury after non-cardiac surgery. Started Nov 2024; status: completed.
02
Drugs
ivabradinePlacebo-COD Research Private Ltd
03
Conditions
Myocardial injury
Beyond the preview
Go deeper on 2024-515226-81-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515226-81-00.